Cargando…

Central Role for Interleukin-2 in Type 1 Diabetes

Type 1 diabetes presents clinically with overt hyperglycemia resulting from progressive immune-mediated destruction of pancreatic β-cells and associated metabolic dysfunction. Combined genetic and immunological studies now highlight deficiencies in both the interleukin-2 (IL-2) receptor and its down...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulme, Maigan A., Wasserfall, Clive H., Atkinson, Mark A., Brusko, Todd M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237657/ https://www.ncbi.nlm.nih.gov/pubmed/22187370 http://dx.doi.org/10.2337/db11-1213

Ejemplares similares

Influence of Membrane CD25 Stability on T Lymphocyte Activity: Implications for Immunoregulation
por: Brusko, Todd M., et al.
Publicado: (2009)

Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
por: O’Kell, Allison L., et al.
Publicado: (2017)

Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses
por: Brusko, Maigan A., et al.
Publicado: (2020)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide
por: Haller, Michael J., et al.
Publicado: (2011)

Membrane marker selection for segmenting single cell spatial proteomics data
por: Dayao, Monica T., et al.
Publicado: (2022)

Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease
por: Ziegler, Anette-G., et al.
Publicado: (2016)

The “Perfect Storm” for Type 1 Diabetes: The Complex Interplay Between Intestinal Microbiota, Gut Permeability, and Mucosal Immunity
por: Vaarala, Outi, et al.
Publicado: (2008)

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
por: Staeva, Teodora P., et al.
Publicado: (2013)

Immunomodulation by Mesenchymal Stem Cells : A Potential Therapeutic Strategy for Type 1 Diabetes
por: Abdi, Reza, et al.
Publicado: (2008)

geneBasis: an iterative approach for unsupervised selection of targeted gene panels from scRNA-seq
por: Missarova, Alsu, et al.
Publicado: (2021)

Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes
por: Petrelli, Alessandra, et al.
Publicado: (2021)

Genetics of Type 1 Diabetes: What's Next?
por: Pociot, Flemming, et al.
Publicado: (2010)

Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2016)

How Does Type 1 Diabetes Develop?: The Notion of Homicide or β-Cell Suicide Revisited
por: Atkinson, Mark A., et al.
Publicado: (2011)

Taking a Daily Vitamin to Prevent Type 1 Diabetes?
por: Wasserfall, Clive, et al.
Publicado: (2009)

Human immune phenotyping reveals accelerated aging in type 1 diabetes
por: Shapiro, Melanie R., et al.
Publicado: (2023)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
por: Skyler, Jay S., et al.
Publicado: (2011)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008)

Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2009)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Serum Trypsinogen Levels in Type 1 Diabetes
por: Li, Xia, et al.
Publicado: (2017)

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
por: Sellmeyer, Deborah E., et al.
Publicado: (2016)

The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes
por: Purcell, Anthony W., et al.
Publicado: (2019)

Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes
por: Xue, Song, et al.
Publicado: (2015)

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

A Global Overview of Precision Medicine in Type 2 Diabetes
por: Fitipaldi, Hugo, et al.
Publicado: (2018)

Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure?
por: Dunne, Jessica L., et al.
Publicado: (2012)

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
por: Haller, Michael J., et al.
Publicado: (2021)

From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes
por: Eizirik, Decio L., et al.
Publicado: (2021)

Evaluation for type 1 diabetes associated autoantibodies in diabetic and non-diabetic Australian terriers and Samoyeds
por: O’Kell, Allison L., et al.
Publicado: (2020)

Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes
por: McCarthy, Mark I., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5pkhoqo5labjdlb7h5p7vcrb0o